89% of Healthcare AI Pilots Die Before Reaching Production. The Reason Isn't What You Think.

I watched a Stripe dashboard tick past a million dollars in a day once. (Different company. Different life, basically.) The number felt like proof that everything was working. It wasn't. Scale doesn't validate anything except your distribution. The product was mediocre, the churn was brutal, and the number on the screen was a vanity metric dressed up as a verdict.

I think about that moment constantly when I look at healthcare AI now.

Billions in investment. Splashy announcements. Demos that run beautifully in controlled conditions and disappear somewhere between the boardroom and the ward. Corti's research, published February 2026, puts the number on it clearly: only 11% of healthcare AI agents actually reach production.

Eleven percent.

The other 89% don't fail because the model was bad. They die for a different reason entirely.

Why Does Healthcare AI Fail to Reach Production?

It fails because of error cascades, not intelligence gaps.

Corti identified what they call 'safety spirals' as the core failure mode: when an unsupervised AI agent makes a mistake in a clinical workflow, whether in coding, documentation, or prior authorization, the error propagates across connected systems faster than any human can intercept it. The downstream system doesn't know anything went wrong. It processes the output as valid, passes it forward, and by the time someone notices, the problem is structural. Healthcare doesn't need smarter AI. It needs AI that knows, at the infrastructure level, what it's allowed to do.

This is the distinction that kills most pilots. A chatbot making a wrong recommendation is annoying and fixable. An agentic system taking a wrong autonomous action in a clinical workflow is potentially invisible until it isn't. Those aren't the same risk profile.

What Actually Blocks AI Deployment in Clinical Settings?

Governance. Every single time.

Not compute costs, not model capability, not integration complexity. The question that kills every pilot I've ever watched die is some version of: 'Who is responsible when this is wrong?' If you can't answer that cleanly, with an audit trail, with escalation logic, with a clear boundary between what the AI does alone and what requires human sign-off, you're not deploying. You're pitching indefinitely.

Corti's response was to build a governed orchestration layer that validates every agent action against clinical protocols in sub-milliseconds before execution. Complete provenance tracking. Real-time audit trail for regulatory compliance. They called it a 'black box recorder' for clinical AI, and the framing is exactly right.

This is also why HANA's infrastructure was designed the way it was from the beginning. Fully open-source. Self-hosted. No dependency on a third-party model provider who can change their terms, update their model quietly, or go offline during a patient interaction. When you're running over one million patient interactions across five countries, zero critical adverse events is not a marketing claim. It's a design constraint you build toward from day one, not an outcome you hope emerges from a sufficiently good model.

Is Healthcare AI Ready for Autonomous Clinical Workflows?

Ready for some. Not for others. And the distinction matters more than most vendors are willing to say clearly.

The workflows where AI reliably reaches production are the ones where the action space is bounded, the escalation criteria are explicit, and a human is genuinely in the loop for anything high-stakes. Scheduling, documentation support, medication reminders, post-discharge check-ins. These are places where AI can operate with real autonomy because the blast radius of an error is manageable and the intervention when something goes wrong is fast.

The workflows where AI keeps dying in pilots are the ones where autonomy bleeds into clinical judgment without adequate guardrails. Prior authorization, diagnostic support, treatment recommendations. Not because the AI can't eventually do these things but because the governance infrastructure to do them safely at production scale doesn't yet exist in most health systems.

Corti launched with production-ready agents for medical coding, documentation, referral coordination, and clinical guidelines. Notice what's on that list and, more importantly, what isn't.

What Does 'Open Source' Actually Mean for Clinical AI Infrastructure?

It means you can look inside. And in a clinical setting, looking inside is the whole game.

Most healthcare AI is a black box. You send data in, you get an output back, and you take the vendor's word for what happened in between. In a HIPAA environment, in a setting where an audit might happen, in any context where a regulator might ask about data handling, that's not a real answer. Contractual assurances don't substitute for architectural transparency, even when the contracts are detailed and the vendor is well-intentioned.

HANA is fully open-source and self-hosted, which means the clinical team can inspect the system, the IT team can validate the data pipeline, and nobody is dependent on a vendor remaining solvent or keeping their API pricing stable. When we say there's no OpenAI dependency, we mean it structurally. The model runs on your infrastructure. The patient data doesn't leave your environment. The cost model changes significantly when you're not locked into per-call API fees from a provider you don't control, and the case studies are public for exactly the reason transparency requires.

Why Do the 11% of AI Deployments Actually Succeed?

Because someone drew a clear line before the first patient interaction.

The line between what the AI decides autonomously and what requires a human. The line between a concerning patient response and a clinical escalation pathway. The line between an automated action and an auditable action. That line isn't drawn by the AI. It's drawn by the people deploying it, before deployment, in writing, with accountability attached to it.

The health systems and clinics that make it to production with AI share one operational discipline: they define those lines precisely and they build the technology around the lines rather than hoping the technology figures out the lines on its own. HANA's results across five countries, three languages, and a million-plus patient interactions come back to the same principle consistently. Thirty-one to one clinic ROI doesn't emerge from better technology. It emerges from better-designed workflows that the technology slots into cleanly.

That's the boring truth nobody puts on a pitch deck. And it's the only truth that actually matters when you're trying to get from pilot to production.

If you want to understand what that workflow design looks like for your practice or health system, start with a conversation, not a demo.

Key Takeaways

The healthcare AI failure rate isn't a model quality problem. It's a governance problem. Agents that can't explain their actions, can't escalate appropriately, and can't be audited after the fact don't survive contact with real clinical environments and real regulatory scrutiny. The 11% that make it to production all share one thing: the organization drew explicit lines between autonomous AI action and human clinical judgment before a single patient was touched. If you're evaluating clinical AI infrastructure, start with governance architecture, not feature lists.

FAQ

Why do most healthcare AI pilots fail to reach production?

The primary failure mode is governance, not model quality. When AI agents make errors in clinical workflows, those errors propagate through connected systems faster than humans can intervene. Without deterministic guardrails, complete audit trails, and explicit escalation criteria, health systems can't take on the liability that autonomous clinical AI action requires.

What makes open-source AI infrastructure safer for clinical deployment?

Open-source, self-hosted AI means clinical and IT teams can inspect the system, validate data handling, and aren't dependent on a vendor's API terms, uptime, or continued existence. Proprietary AI systems ask health systems to substitute contractual assurances for architectural transparency, which creates real compliance and liability exposure in regulated clinical environments.

How do you measure ROI for clinical AI before committing to full deployment?

Start with a narrow, high-volume, low-risk workflow where the baseline outcome is clearly measurable: post-discharge call completion rate, medication adherence check-ins, no-show reduction. Set the baseline before deploying anything. Measure actual engagement rate, not attempt rate, alongside escalation frequency and downstream outcomes. ROI projections built without baseline instrumentation almost always disappoint when it's time to defend the investment.